
|Articles|March 1, 2006
- Volume 0 0
KENTUCKY LEGISLATURE EYES NEW Rx IMPORT PROPOSAL
Advertisement
Pharmacists in Kentucky soon may be allowed to stock their prescriptiondepartment shelves with low-cost drugs from Canada or other countries. Newlegislation to that effect is being debated by state lawmakers.
The bill directs state officials to seek federal authority to permit Kentuckypharmacists as well as drug distributors and wholesalers to obtain drugs fromlicensed, foreign suppliers. State auditors told the legislature that opening thedoor for cheaper prescription drug imports could significantly reduce healthcosts for Kentucky consumers and taxpayers.
Articles in this issue
over 20 years ago
British Poll Shows People Denying Weight Problemsover 20 years ago
Suing a Lawyer for Malpractice?over 20 years ago
Pharmacists—Cops or Not? (Part 1)over 20 years ago
Can You Read These Rxs?over 20 years ago
Alternative Measures for Treating Pediculosisover 20 years ago
Compounding Hotlineover 20 years ago
Obesity May Lead to Kidney Failureover 20 years ago
Body Fat Associated with Alzheimer's Proteinover 20 years ago
Midlife Obesity May Cause Heart Diseaseover 20 years ago
The Evolution of Imprint IdentificationAdvertisement
Related to this article

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.

Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Advertisement
Advertisement
Trending on Pharmacy Times
1
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
2
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
5


